Name | Title | Contact Details |
---|
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.
Hinge Health is pioneering the world`s most patient-centered Digital Musculoskeletal (MSK) Clinicâ„¢. Four in five employers and 90% of health plans with a digital MSK solution have chosen Hinge Health. Hinge Health reduces MSK pain, opioid use, and surgeries by pairing advanced wearable sensors and computer vision technology with a comprehensive Clinical Care Team with doctors of physical therapy, physicians, board-certified health coaches, and more. Hinge Health`s Digital MSK Clinic is connected with 750,000+ in-person providers and enables real-time interventions for proven medical claims reduction. Available to millions of members, Hinge Health is the #1 Digital MSK Clinic with 500+ health plans and employers customers, including Boeing, Salesforce, and US Foods. Hinge Health has raised $826M to date with offices across San Francisco, Austin, Chicago, Denver, Minneapolis, Portland, Seattle and more.
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
The California Poison Control System (CPCS) is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
RELATIENT mobilizes existing, real-time healthcare data to automatically build relationships and promote loyalty with the healthcare consumer, drive compliance and adherence, boost revenue, lower costs, and build lasting relationships like no other Patient Engagement and Messaging platform available today. Compatible with most EHR/PM system on the market, RELATIENT boosts productivity by completely automating necessary outreach in the categories of Appointments, Patient Payments, Health Maintenance, Satisfaction Surveys, Self-Scheduling, and Demand messaging to patients. Reach out to us, you`ll be glad you did!